Cataract News and Research

Latest Cataract News and Research

NEI-funded research aims to prevent or reverse progression of cataracts

Research funded by the National Eye Institute aims to reverse progression of cataracts- the most common cause of blindness worldwide- or to prevent them from forming altogether.

30 Jun 2017

New contact lens therapy shows potential to impact rising prevalence of myopia in children

A pioneering contact lens therapy has considerable potential to impact the rising prevalence of myopia (nearsightedness) in children, according to highly-anticipated study outcomes presented today at the British Contact Lens Association Clinical Conference in Liverpool, England.

12 Jun 2017

Study reveals unique retinal scar in Ebola survivors

Researchers from the University of Liverpool have conducted a study of Ebola survivors to determine if the virus has any specific effects on the back on the eye using an ultra widefield retinal camera.

16 May 2017

Shire and Parion Sciences to collaborate on P-321 for ophthalmic indications

Shire plc and Parion Sciences, Inc. have announced they have entered into an agreement granting Shire exclusive worldwide rights to develop and commercialize P-321. Shire will lead development of P-321, an investigational epithelial sodium channel (ENaC) inhibitor for the potential treatment of dry eye disease in adults, with the opportunity for Parion to co-fund.

3 May 2017

Research reveals 9.8 million Brits risk losing their sight after shunning eye tests

The Vision of Britain report, commissioned by Optegra Eye Health Care, shows an alarming percentage of Britain’s eye problems are left too late to treat, leaving 9.8 million of us living in fear of losing our sight.

3 May 2017

Healthy Vision Month: NEI focuses on women’s eye health

May is Healthy Vision Month when the National Eye Institute encourages everyone to make eye health a priority. This message is especially important for women, who make up two-thirds of all people living with blindness or visual impairment from diseases such as age-related macular degeneration, glaucoma, and cataract.

29 Apr 2017

Takeda announces accelerated approval from FDA for new lung cancer treatment

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that ALUNBRIG (brigatinib) has received Accelerated Approval from the U.S. Food and Drug Administration for the treatment of patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer who have progressed on or are intolerant to crizotinib.

28 Apr 2017

Analysis finds high infection rates with contact lens than with LASIK to correct vision

Which causes fewer eye infections - contact lens wear or LASIK surgery? While traditionally contacts were thought to be safer than a surgical procedure, an analysis by ophthalmologists from the Hamilton Eye Institute at the University of Tennessee Health Science Center indicates otherwise.

21 Apr 2017

Glaucoma research can help make treatment more accessible in developing countries

Glaucoma in developing countries represents a significant health crisis. The great majority of people in developing countries aren't ever tested for glaucoma, so diagnosis and treatment are rare. And if they are diagnosed, they often can't pay for medication, assuming medications are available.

21 Apr 2017

Clinical research trial investigates new treatment approach for early-stage eye melanoma

A first-of-its-kind, potentially groundbreaking new option for treating a form of eye cancer is now in its first phase-1 clinical research trial at Wills Eye Hospital in Philadelphia.

30 Mar 2017

Hepatitis B and C patients more likely to develop Parkinson's disease, study finds

The viruses hepatitis B and C may both be associated with an increased risk of Parkinson's disease, according to a study published in the March 29, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology. The hepatitis virus affects the liver.

29 Mar 2017

Optegra Eye Health Care’s flagship Central London hospital celebrates first anniversary

Optegra Eye Health Care’s flagship Central London hospital, situated in the prestigious Harley Street district, has given the gift of improved vision back to hundreds of people since first opening its doors in January 2016.

15 Feb 2017

UMass Amherst discovery holds promise for revolutionizing treatment of cataracts and presbyopia

The University of Massachusetts Amherst recently licensed a new technology to Janssen Pharmaceuticals, Inc. that holds promise of revolutionizing the treatment of cataracts and presbyopia, based on early phase discoveries by polymer physicist Murugappan Muthukumar and former graduate student Ben Mohr regarding the fundamental science of proteins in the lens of the human eye.

9 Feb 2017

Wills Eye expert discusses what patients need to know about Age-Related Macular Degeneration

Carl D. Regillo, MD Chief of the Wills Eye Hospital Retina Service discusses what patients need to know about Age-Related Macular Degeneration.

8 Feb 2017

Access to anesthesia care not increased when states ‘opt-out’ of Medicare rule, study finds

Patient access to anesthesia care for seven common surgical procedures is not increased when states "opt-out" of the Medicare rule that requires anesthesia to be administered with physician supervision, reports a study published in the Online First edition of Anesthesiology, the peer-reviewed medical journal of the American Society of Anesthesiologists.

20 Jan 2017

VisionCare receives FDA approval to begin clinical study of telescope implant in post-cataract patients

VisionCare, Inc. ("VisionCare"), a developer of advanced visual prosthetic devices for the treatment of age-related macular degeneration (AMD), today announced the U.S. Food and Drug Administration (FDA) approved the company's investigational device exemption for a new U.S. clinical study.

12 Jan 2017

Sight Sciences receives Health Canada approval for TRAB 360 Trabeculotomy System

Sight Sciences, Inc., a venture-backed, commercial-stage ophthalmic medical device company announced today that it has received Health Canada approval for the TRAB 360 Trabeculotomy System.

23 Dec 2016

New contact lens therapy effective in slowing progression of juvenile-onset myopia, study shows

A groundbreaking contact lens therapy has potential to impact the fast-growing issue of myopia (nearsightedness) among children, based on research presented at the American Academy of Optometry's 95th Annual Meeting.

8 Dec 2016

Older adults with cataracts more likely to have depressive symptoms, study shows

Older adults with cataracts are more likely to have symptoms of depression, reports a study in the December issue of Optometry and Vision Science, official journal of the American Academy of Optometry.

2 Dec 2016

Statins can help prevent first time heart attacks, strokes in adults with cardiovascular risk factors

Cholesterol-lowering drugs help prevent heart attacks and strokes in adults with cardiovascular risk factors such as high cholesterol, high blood pressure, diabetes and smoking, but have not yet had a heart attack or stroke, according to a large-scale analysis of clinical trial data led by the OHSU Pacific Northwest Evidence-Based Practice Center.

14 Nov 2016

Cataract News and Research

Latest Cataract News and Research

NEI-funded research aims to prevent or reverse progression of cataracts

New contact lens therapy shows potential to impact rising prevalence of myopia in children

Study reveals unique retinal scar in Ebola survivors

Shire and Parion Sciences to collaborate on P-321 for ophthalmic indications

Research reveals 9.8 million Brits risk losing their sight after shunning eye tests

Healthy Vision Month: NEI focuses on women’s eye health

Takeda announces accelerated approval from FDA for new lung cancer treatment

Analysis finds high infection rates with contact lens than with LASIK to correct vision

Glaucoma research can help make treatment more accessible in developing countries

Clinical research trial investigates new treatment approach for early-stage eye melanoma

Hepatitis B and C patients more likely to develop Parkinson's disease, study finds

Optegra Eye Health Care’s flagship Central London hospital celebrates first anniversary

UMass Amherst discovery holds promise for revolutionizing treatment of cataracts and presbyopia

Wills Eye expert discusses what patients need to know about Age-Related Macular Degeneration

Access to anesthesia care not increased when states ‘opt-out’ of Medicare rule, study finds

VisionCare receives FDA approval to begin clinical study of telescope implant in post-cataract patients

Sight Sciences receives Health Canada approval for TRAB 360 Trabeculotomy System

New contact lens therapy effective in slowing progression of juvenile-onset myopia, study shows

Older adults with cataracts more likely to have depressive symptoms, study shows

Statins can help prevent first time heart attacks, strokes in adults with cardiovascular risk factors

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Cataract News and Research

Latest Cataract News and Research

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Newsletters you may be interested in